Annals of internal medicine
-
Comment
Guselkumab safely improved clinical outcomes in biologic-naive patients with psoriatic arthritis.
Mease PJ, Rahman P, Gottlieb AB, et al. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2020;395:1126-36. 32178766.
-
Multicenter Study
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey.
The evolving outbreak of coronavirus disease 2019 (COVID-19) is requiring social distancing and other measures to protect public health. However, messaging has been inconsistent and unclear. ⋯ National Institutes of Health.
-
Observational Study
Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy.
Current guidelines recommend a 10-year interval between screening colonoscopies, but evidence is limited. ⋯ Polish Ministry of Health.